UniProt ID | 1433G_HUMAN | |
---|---|---|
UniProt AC | P61981 | |
Protein Name | 14-3-3 protein gamma | |
Gene Name | YWHAG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 247 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.. | |
Protein Sequence | MVDREQLVQKARLAEQAERYDDMAAAMKNVTELNEPLSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTSADGNEKKIEMVRAYREKIEKELEAVCQDVLSLLDNYLIKNCSETQYESKVFYLKMKGDYYRYLAEVATGEKRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNYSVFYYEIQNAPEQACHLAKTAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQDDDGGEGNN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Sulfoxidation | -------MVDREQLV -------CCCHHHHH | 6.80 | 21406390 | |
2 | Acetylation | ------MVDREQLVQ ------CCCHHHHHH | 10.78 | 14534293 | |
10 | Malonylation | DREQLVQKARLAEQA CHHHHHHHHHHHHHH | 28.17 | 26320211 | |
10 | Ubiquitination | DREQLVQKARLAEQA CHHHHHHHHHHHHHH | 28.17 | 23000965 | |
10 | Acetylation | DREQLVQKARLAEQA CHHHHHHHHHHHHHH | 28.17 | 25953088 | |
20 | Phosphorylation | LAEQAERYDDMAAAM HHHHHHHHHHHHHHH | 14.06 | 6852815 | |
28 | Ubiquitination | DDMAAAMKNVTELNE HHHHHHHHCHHHHCC | 43.47 | 24816145 | |
31 | Phosphorylation | AAAMKNVTELNEPLS HHHHHCHHHHCCCCC | 44.12 | 21712546 | |
38 | Phosphorylation | TELNEPLSNEERNLL HHHCCCCCHHHHHHH | 53.57 | 55443151 | |
46 | Phosphorylation | NEERNLLSVAYKNVV HHHHHHHHHHHHHHH | 14.10 | 19664994 | |
49 | Phosphorylation | RNLLSVAYKNVVGAR HHHHHHHHHHHHCCC | 10.84 | 22617229 | |
50 | Ubiquitination | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 23000965 | |
50 | Methylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | - | |
50 | Neddylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 32015554 | |
50 | Acetylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 129687 | |
58 | Phosphorylation | NVVGARRSSWRVISS HHHCCCCCCCEEECC | 28.79 | 23882029 | |
59 | Phosphorylation | VVGARRSSWRVISSI HHCCCCCCCEEECCC | 19.65 | 7785495 | |
64 | Phosphorylation | RSSWRVISSIEQKTS CCCCEEECCCCHHCC | 23.54 | 27273156 | |
65 | Phosphorylation | SSWRVISSIEQKTSA CCCEEECCCCHHCCC | 21.01 | 23927012 | |
69 | Malonylation | VISSIEQKTSADGNE EECCCCHHCCCCCCH | 31.49 | 26320211 | |
69 | Ubiquitination | VISSIEQKTSADGNE EECCCCHHCCCCCCH | 31.49 | 32142685 | |
69 | Acetylation | VISSIEQKTSADGNE EECCCCHHCCCCCCH | 31.49 | 23954790 | |
70 | Phosphorylation | ISSIEQKTSADGNEK ECCCCHHCCCCCCHH | 28.92 | 23927012 | |
71 | Phosphorylation | SSIEQKTSADGNEKK CCCCHHCCCCCCHHH | 31.25 | 25159151 | |
77 | Ubiquitination | TSADGNEKKIEMVRA CCCCCCHHHHHHHHH | 64.15 | 29967540 | |
78 | Ubiquitination | SADGNEKKIEMVRAY CCCCCHHHHHHHHHH | 37.41 | 24816145 | |
110 | Ubiquitination | LLDNYLIKNCSETQY HHHHHHHHCCCCCCC | 49.67 | 32015554 | |
113 | Phosphorylation | NYLIKNCSETQYESK HHHHHCCCCCCCCCE | 53.74 | 26437602 | |
115 | Phosphorylation | LIKNCSETQYESKVF HHHCCCCCCCCCEEE | 21.84 | 28152594 | |
117 | Phosphorylation | KNCSETQYESKVFYL HCCCCCCCCCEEEEE | 29.59 | 24927040 | |
119 | Phosphorylation | CSETQYESKVFYLKM CCCCCCCCEEEEEEE | 29.23 | 28152594 | |
120 | Ubiquitination | SETQYESKVFYLKMK CCCCCCCEEEEEEEC | 25.15 | 23000965 | |
120 | Acetylation | SETQYESKVFYLKMK CCCCCCCEEEEEEEC | 25.15 | 26822725 | |
120 | Succinylation | SETQYESKVFYLKMK CCCCCCCEEEEEEEC | 25.15 | 23954790 | |
123 | Phosphorylation | QYESKVFYLKMKGDY CCCCEEEEEEECCHH | 14.38 | 28152594 | |
125 | Succinylation | ESKVFYLKMKGDYYR CCEEEEEEECCHHHH | 27.47 | 23954790 | |
125 | Acetylation | ESKVFYLKMKGDYYR CCEEEEEEECCHHHH | 27.47 | 23236377 | |
125 | Ubiquitination | ESKVFYLKMKGDYYR CCEEEEEEECCHHHH | 27.47 | 23000965 | |
127 | Ubiquitination | KVFYLKMKGDYYRYL EEEEEEECCHHHHHH | 47.22 | 23000965 | |
130 | Phosphorylation | YLKMKGDYYRYLAEV EEEECCHHHHHHHHH | 9.86 | 28152594 | |
131 | Phosphorylation | LKMKGDYYRYLAEVA EEECCHHHHHHHHHH | 9.49 | 28152594 | |
133 | Phosphorylation | MKGDYYRYLAEVATG ECCHHHHHHHHHHCC | 8.31 | 28152594 | |
139 | Phosphorylation | RYLAEVATGEKRATV HHHHHHHCCCCEEEE | 51.56 | 46155637 | |
142 | Acetylation | AEVATGEKRATVVES HHHHCCCCEEEEEEC | 48.99 | 23749302 | |
142 | Malonylation | AEVATGEKRATVVES HHHHCCCCEEEEEEC | 48.99 | 26320211 | |
142 | Ubiquitination | AEVATGEKRATVVES HHHHCCCCEEEEEEC | 48.99 | 21906983 | |
145 | Phosphorylation | ATGEKRATVVESSEK HCCCCEEEEEECCHH | 29.17 | 20068231 | |
149 | Phosphorylation | KRATVVESSEKAYSE CEEEEEECCHHHHHH | 31.99 | 20068231 | |
150 | Phosphorylation | RATVVESSEKAYSEA EEEEEECCHHHHHHH | 29.61 | 21406692 | |
152 | Ubiquitination | TVVESSEKAYSEAHE EEEECCHHHHHHHHH | 55.35 | 32142685 | |
152 | Acetylation | TVVESSEKAYSEAHE EEEECCHHHHHHHHH | 55.35 | 25953088 | |
154 | Phosphorylation | VESSEKAYSEAHEIS EECCHHHHHHHHHHC | 20.36 | 28152594 | |
155 | Phosphorylation | ESSEKAYSEAHEISK ECCHHHHHHHHHHCH | 32.92 | 72249055 | |
162 | Acetylation | SEAHEISKEHMQPTH HHHHHHCHHHCCCCC | 58.25 | 23954790 | |
162 | Ubiquitination | SEAHEISKEHMQPTH HHHHHHCHHHCCCCC | 58.25 | 21906983 | |
165 | Sulfoxidation | HEISKEHMQPTHPIR HHHCHHHCCCCCCCC | 5.53 | 30846556 | |
168 | Phosphorylation | SKEHMQPTHPIRLGL CHHHCCCCCCCCHHH | 24.32 | 20068231 | |
179 | Phosphorylation | RLGLALNYSVFYYEI CHHHEEEEEEEEEEC | 13.68 | 51167 | |
180 | Phosphorylation | LGLALNYSVFYYEIQ HHHEEEEEEEEEECC | 12.50 | 30834819 | |
183 | Phosphorylation | ALNYSVFYYEIQNAP EEEEEEEEEECCCCH | 9.68 | 20873877 | |
184 | Phosphorylation | LNYSVFYYEIQNAPE EEEEEEEEECCCCHH | 8.62 | 20873877 | |
198 | Ubiquitination | EQACHLAKTAFDDAI HHHHHHHHHHHHHHH | 46.90 | - | |
199 | Phosphorylation | QACHLAKTAFDDAIA HHHHHHHHHHHHHHH | 27.27 | 19664994 | |
210 | Phosphorylation | DAIAELDTLNEDSYK HHHHHHHCCCCCCCC | 44.07 | 28450419 | |
215 | Phosphorylation | LDTLNEDSYKDSTLI HHCCCCCCCCCHHHH | 28.09 | 27422710 | |
216 | Phosphorylation | DTLNEDSYKDSTLIM HCCCCCCCCCHHHHH | 31.01 | 119397 | |
217 | Ubiquitination | TLNEDSYKDSTLIMQ CCCCCCCCCHHHHHH | 49.51 | 32015554 | |
219 | Phosphorylation | NEDSYKDSTLIMQLL CCCCCCCHHHHHHHH | 22.44 | 28450419 | |
220 | Phosphorylation | EDSYKDSTLIMQLLR CCCCCCHHHHHHHHH | 30.36 | 19664994 | |
231 | Phosphorylation | QLLRDNLTLWTSDQQ HHHHCCCEEEECCCC | 26.89 | 26852163 | |
234 | Phosphorylation | RDNLTLWTSDQQDDD HCCCEEEECCCCCCC | 26.07 | 20071362 | |
235 | Phosphorylation | DNLTLWTSDQQDDDG CCCEEEECCCCCCCC | 23.11 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
59 | S | Phosphorylation | Kinase | LATS2 | Q9NRM7 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 1433G_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 1433G_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Proteomics-based target identification: bengamides as a new class ofmethionine aminopeptidase inhibitors."; Towbin H., Bair K.W., DeCaprio J.A., Eck M.J., Kim S., Kinder F.R.,Morollo A., Mueller D.R., Schindler P., Song H.K., van Oostrum J.,Versace R.W., Voshol H., Wood J., Zabludoff S., Phillips P.E.; J. Biol. Chem. 278:52964-52971(2003). Cited for: CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT VAL-2, AND MASSSPECTROMETRY. |